0000950170-24-041790.txt : 20240404 0000950170-24-041790.hdr.sgml : 20240404 20240404160048 ACCESSION NUMBER: 0000950170-24-041790 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240402 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dooley Mary Beth CENTRAL INDEX KEY: 0002015112 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37566 FILM NUMBER: 24823079 MAIL ADDRESS: STREET 1: 301 BINNEY ST., SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNLOGIC, INC. CENTRAL INDEX KEY: 0001527599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 261824804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-401-9975 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Mirna Therapeutics, Inc. DATE OF NAME CHANGE: 20110809 4 1 ownership.xml 4 X0508 4 2024-04-02 0001527599 SYNLOGIC, INC. SYBX 0002015112 Dooley Mary Beth C/O SYNLOGIC, INC. 301 BINNEY STREET, SUITE 402 CAMBRIDGE MA 02142 false true false false Head of Finance false Common Stock 2024-04-02 4 S false 188 1.73 D 15231 D Represents the number of shares sold by the reporting person on April 2, 2024 to cover the tax liability in connection with the vesting of four restricted stock awards, vesting on April 1, 2024, that were granted in 2020, 2021, 2022 and 2023. /s/ Mary Beth Dooley 2024-04-04